Ossen Innovation Stock Forecast, Price & News

Ossen Innovation (NASDAQ:OSN) Frequently Asked Questions

What stocks does MarketBeat like better than Ossen Innovation?

Wall Street analysts have given Ossen Innovation a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Ossen Innovation wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Ossen Innovation?

Ossen Innovation saw a increase in short interest in August. As of August 31st, there was short interest totaling 27,100 shares, an increase of 115.1% from the August 15th total of 12,600 shares. Based on an average daily trading volume, of 61,600 shares, the short-interest ratio is currently 0.4 days.
View Ossen Innovation's Short Interest.

How has Ossen Innovation's stock been impacted by COVID-19 (Coronavirus)?

Ossen Innovation's stock was trading at $2.00 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, OSN shares have increased by 152.5% and is now trading at $5.0499.
View which stocks have been most impacted by COVID-19.

Who are Ossen Innovation's key executives?

Ossen Innovation's management team includes the following people:

• Wei Hua, Director, Chief Executive & Financial Officer

Who are some of Ossen Innovation's key competitors?

Some companies that are related to Ossen Innovation include CITIC (CTPCY), ArcelorMittal (MT), Nucor (NUE), POSCO (PKX), Sumitomo (SSUMY), Steel Dynamics (STLD), Tenaris (TS), Ternium (TX), United States Steel (X), Aperam (APEMY), Commercial Metals (CMC), Grupo Simec (SIM), Usinas Siderúrgicas de Minas Gerais (USNZY), Carpenter Technology (CRS) and Mechel PAO (MTL).
View all of OSN's competitors.

What other stocks do shareholders of Ossen Innovation own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Ossen Innovation investors own include Allena Pharmaceuticals (ALNA), British American Tobacco (BTI), Dominion Energy (D), AbbVie (ABBV), AcelRx Pharmaceuticals (ACRX), Ampio Pharmaceuticals (AMPE), American Superconductor (AMSC), Athersys (ATHX), BCE (BCE) and BIOLASE (BIOL).

What is Ossen Innovation's stock symbol?

Ossen Innovation trades on the NASDAQ under the ticker symbol "OSN."

Who are Ossen Innovation's major shareholders?

Ossen Innovation's stock is owned by many different retail and institutional investors. Top institutional shareholders include Renaissance Technologies LLC (1.81%) and Commonwealth Equity Services LLC (0.64%).

Which institutional investors are buying Ossen Innovation stock?

OSN stock was acquired by a variety of institutional investors in the last quarter, including Commonwealth Equity Services LLC, and Renaissance Technologies LLC.

How do I buy shares of Ossen Innovation?

Shares of OSN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Ossen Innovation's stock price today?

One share of OSN stock can currently be purchased for approximately $5.05.

How much money does Ossen Innovation make?

Ossen Innovation has a market capitalization of $33.33 million and generates $138.58 million in revenue each year.

How many employees does Ossen Innovation have?

Ossen Innovation employs 171 workers across the globe.

What is Ossen Innovation's official website?

The official website for Ossen Innovation is www.osseninnovation.com.

Where are Ossen Innovation's headquarters?

Ossen Innovation is headquartered at 518 SHANGCHENG ROAD FLOOR 17, SHANGHAI F4, 200120.

How can I contact Ossen Innovation?

Ossen Innovation's mailing address is 518 SHANGCHENG ROAD FLOOR 17, SHANGHAI F4, 200120. The construction company can be reached via phone at 862168888886 or via email at [email protected].